This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.


Introduction: New Directions in the Treatment of Atypical Depression

Michael E. Thase, MD

Published: February 15, 2007

Article Abstract

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

In this supplement, each article focuses on a different aspect of atypical depression. First, Jonathan R. T. Davidson, M.D., examines the evolution of the concept of atypical depression; second, Gordon B. Parker, M.D.,Ph.D., D.Sc., discusses the validity of the current concept and suggests a new model for viewing atypical depression from a personality spectrum perspective; third, JonathanW. Stewart, M.D., presents a review of the treatment literature, focusing on established therapies and ending with the work on selective serotonin reuptake inhibitors(SSRIs); and finally, Mark H. Rapaport, M.D.,

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Volume: 9

Quick Links: Depression (MDD)


Sign-up to stay
up-to-date today!


Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...